These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21726872)

  • 1. Downstream processing of Vero cell-derived human influenza A virus (H1N1) grown in serum-free medium.
    He C; Yang Z; Tong K
    J Chromatogr A; 2011 Aug; 1218(31):5279-85. PubMed ID: 21726872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
    Rourou S; van der Ark A; van der Velden T; Kallel H
    Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.
    Genzel Y; Fischer M; Reichl U
    Vaccine; 2006 Apr; 24(16):3261-72. PubMed ID: 16472544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccines.
    Kalbfuss B; Genzel Y; Wolff M; Zimmermann A; Morenweiser R; Reichl U
    Biotechnol Bioeng; 2007 May; 97(1):73-85. PubMed ID: 16921531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of influenza virus in serum-free mammalian cell cultures.
    Merten OW; Manuguerra JC; Hannoun C; van der Werf S
    Dev Biol Stand; 1999; 98():23-37; discussion 73-4. PubMed ID: 10494957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical optimization of influenza H1N1 production from batch cultures of suspension Vero cells (sVero).
    Paillet C; Forno G; Soldano N; Kratje R; Etcheverrigaray M
    Vaccine; 2011 Sep; 29(41):7212-7. PubMed ID: 21756959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vero-cell rabies vaccine produced using serum-free medium.
    Frazatti-Gallina NM; Mourão-Fuches RM; Paoli RL; Silva ML; Miyaki C; Valentini EJ; Raw I; Higashi HG
    Vaccine; 2004 Dec; 23(4):511-7. PubMed ID: 15530700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of yellow fever virus in microcarrier-based Vero cell cultures.
    Souza MC; Freire MS; Schulze EA; Gaspar LP; Castilho LR
    Vaccine; 2009 Oct; 27(46):6420-3. PubMed ID: 19559120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of cell culture-derived human influenza A virus by size-exclusion and anion-exchange chromatography.
    Kalbfuss B; Wolff M; Morenweiser R; Reichl U
    Biotechnol Bioeng; 2007 Apr; 96(5):932-44. PubMed ID: 16937411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downstream processing of MDCK cell-derived equine influenza virus.
    Nayak DP; Lehmann S; Reichl U
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 823(2):75-81. PubMed ID: 16009601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells.
    Chen A; Poh SL; Dietzsch C; Roethl E; Yan ML; Ng SK
    BMC Biotechnol; 2011 Aug; 11():81. PubMed ID: 21835017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Vero cell-derived influenza whole virus vaccine.
    Kistner O; Barrett PN; Mundt W; Reiter M; Schober-Bendixen S; Eder G; Dorner F
    Dev Biol Stand; 1999; 98():101-10; discussion 111. PubMed ID: 10494963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of adsorbents selection on capture efficiency of cell culture derived human influenza viruses.
    Opitz L; Lehmann S; Zimmermann A; Reichl U; Wolff MW
    J Biotechnol; 2007 Sep; 131(3):309-17. PubMed ID: 17765993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.
    Govorkova EA; Kodihalli S; Alymova IV; Fanget B; Webster RG
    Dev Biol Stand; 1999; 98():39-51; discussion 73-4. PubMed ID: 10494958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process.
    George M; Farooq M; Dang T; Cortes B; Liu J; Maranga L
    Biotechnol Bioeng; 2010 Aug; 106(6):906-17. PubMed ID: 20589670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of Vero cell derived live replication deficient influenza A and B virus by ion exchange monolith chromatography.
    Banjac M; Roethl E; Gelhart F; Kramberger P; Jarc BL; Jarc M; Strancar A; Muster T; Peterka M
    Vaccine; 2014 May; 32(21):2487-92. PubMed ID: 24631091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A flow-through chromatography purification process for Vero cell-derived influenza virus (H7N9).
    Fei C; Gao J; Fei C; Ma L; Zhu W; He L; Wu Y; Song S; Li W; Zhou J; Liao G
    J Virol Methods; 2022 Mar; 301():114408. PubMed ID: 34896455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfated membrane adsorbers for economic pseudo-affinity capture of influenza virus particles.
    Opitz L; Lehmann S; Reichl U; Wolff MW
    Biotechnol Bioeng; 2009 Aug; 103(6):1144-54. PubMed ID: 19449393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media.
    Genzel Y; Olmer RM; Schäfer B; Reichl U
    Vaccine; 2006 Aug; 24(35-36):6074-87. PubMed ID: 16781022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture.
    Liu CC; Lian WC; Butler M; Wu SC
    Vaccine; 2007 Jan; 25(1):19-24. PubMed ID: 16919374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.